Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Strong Buy

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Neutral

Analyst Rating

Sell

Upgrade To View Simple Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Exponential Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Relative Strength Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Standard Deviation Rating

Upgrade

Upgrade To Get Access

Upgrade To View Williams %R Rating

Upgrade

Upgrade To Get Access

Upgrade To View Average Directional Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Insider Trading Rating

Upgrade

Upgrade To Get Access

Wall Street Data Solutions Rating

Neutral

B

Dare Bioscience, Inc. Common Stock (DARE)

Pharmaceutical Preparations

https://www.darebioscience.com

Dare Bioscience Inc is a biopharmaceutical company committed to advancing innovative products for women's health. The company identifies, develops and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, primarily in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in advanced clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.

3655 NOBEL DRIVE, SUITE 260
SAN DIEGO, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

04/10/2014

Market Cap

29,912,260

Shares Outstanding

98,560,000

Weighted SO

98,562,344

Total Employees

N/A

Upcoming Earnings

08/12/2024

Similar Tickers

SNSE --.--%

NXTC --.--%

NUVB --.--%

GRPH --.--%

MACK --.--%

OCUP --.--%

RVPH --.--%

PLX --.--%

EYPT --.--%

Beta

1.3730

Last Div

0.0000

Range

3.05-8.652

Chg

0.0200

Avg Vol

52560

Mkt Cap

29912260

Exch

NASDAQ

Country

US

Phone

858 926 7655

DCF Diff

3.3256

DCF

0.0844

Div Yield

0.0000

P/S

10.5339

EV Multiple

-0.7204

P/FV

11.0198

Div Yield %

0.0000

P/E

-4.0880

PEG

0.0381

Payout

0.0000

Current Ratio

1.4277

Quick Ratio

1.4277

Cash Ratio

1.1251

DSO

115.9637

DIO

0.0080

Op Cycle

115.9718

DPO

15335.2194

CCC

-15219.2477

Gross Margin

0.9840

Op Margin

-9.4615

Pretax Margin

-2.5360

Net Margin

-2.5360

Eff Tax Rate

0.0060

ROA

-0.3051

ROE

1.8389

ROCE

-2.9798

NI/EBT

1.0000

EBT/EBIT

0.2680

EBIT/Rev

-9.4615

Debt Ratio

0.2032

D/E

1.7953

LT Debt/Cap

0.6172

Total Debt/Cap

0.6423

Int Coverage

-3501.0614

CF/Debt

-6.1631

Equity Multi

8.8363

Rec Turnover

3.1475

Pay Turnover

0.0238

Inv Turnover

45455.0000

FA Turnover

1.6060

Asset Turnover

0.1203

OCF/Share

-3.5143

FCF/Share

-3.5900

Cash/Share

1.9515

OCF/Sales

-10.4097

FCF/OCF

1.0215

CF Coverage

-6.1631

ST Coverage

-60.5543

CapEx Coverage

-46.4246

Div&CapEx Cov

-46.4246

P/BV

11.0198

P/B

11.0198

P/S

10.5339

P/E

-4.0880

P/FCF

-0.9906

P/OCF

-0.9959

P/CF

-0.9959

PEG

0.0381

P/S

10.5339

EV Multiple

-0.7204

P/FV

11.0198

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Dec 26, 08:00 Daré Bioscience Secures $12 million in Royalty-backed Investment Structure

Revenue Product Segmentation